Last reviewed · How we verify
Mycophenolate mofetil,methotrexate
Mycophenolate mofetil,methotrexate is a Small molecule drug developed by Assistance Publique - Hôpitaux de Paris. It is currently FDA-approved.
Mycophenolate mofetil is a small molecule inhibitor of inosine-5'-monophosphate dehydrogenase (IMPDH). It is used to treat various hematologic malignancies, including multiple myeloma, lymphocytic leukemia, lymphoma, acute leukemia, and chronic myelogenous leukemia, as indicated by clinical trials on ClinicalTrials.gov.
At a glance
| Generic name | Mycophenolate mofetil,methotrexate |
|---|---|
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256) (PHASE2)
- Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia (PHASE2)
- This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis (PHASE2)
- Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation (PHASE1, PHASE2)
- Targeted Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation (PHASE3)
- Utilization of a Microdevice for Psoriasis and Atopic Dermatitis (PHASE4)
- Registry for Systemic Eczema Treatments
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Mycophenolate mofetil,methotrexate CI brief — competitive landscape report
- Mycophenolate mofetil,methotrexate updates RSS · CI watch RSS
- Assistance Publique - Hôpitaux de Paris portfolio CI
Frequently asked questions about Mycophenolate mofetil,methotrexate
What is Mycophenolate mofetil,methotrexate?
Who makes Mycophenolate mofetil,methotrexate?
What development phase is Mycophenolate mofetil,methotrexate in?
Related
- Manufacturer: Assistance Publique - Hôpitaux de Paris — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing